SR One and Biogen Idec New Ventures Join as New Investors SOUTH SAN FRANCISCO, Calif., Sept. 8 (HSMN NewsFeed) — iPierian, Inc., the major biopharmaceutical company using patient-derived induced pluripotent stem cells (iPSCs) for drug discovery, …
Biopharmaceuticals, Regenerative Medicine, Venture Capital
iPierian, stem cell

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “iPierian Announces Second Close of $28 Million Series B Financing”
Leave a Comment